Skip to main content
. Author manuscript; available in PMC: 2014 Apr 11.
Published in final edited form as: Nat Genet. 2013 Mar 17;45(5):518–521. doi: 10.1038/ng.2581

Figure 4. Cell proliferation in pulmonary artery smooth muscle cells (PA-SMC) treated with CBLN2.

Figure 4

Cell proliferation was measured by BrdU incorporation in PA-SMC cultured in complete medium with 5 % fetal calf serum (FCS) or depleted medium (0.2 % FCS) and treated with CBLN2 peptide at concentrations ranging from 0 to 10 nM. A significant decrease in the proliferation of PA-SMC was observed when cells were treated with increasing doses of CBLN2 peptide. Each symbol represents the value for one experiment. The log-linear regression line is indicated (n = 4, log-linear regression test, P = 6.33 x 10−4).